Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Strata Critical Medical (SRTAW) Equity Ratio (2019 - 2025)

Historic Equity Ratio for Strata Critical Medical (SRTAW) over the last 7 years, with Q3 2025 value amounting to 0.84.

  • Strata Critical Medical's Equity Ratio rose 234.29% to 0.84 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.84, marking a year-over-year increase of 234.29%. This contributed to the annual value of 0.86 for FY2024, which is 884.45% up from last year.
  • Per Strata Critical Medical's latest filing, its Equity Ratio stood at 0.84 for Q3 2025, which was up 234.29% from 0.87 recorded in Q2 2025.
  • In the past 5 years, Strata Critical Medical's Equity Ratio ranged from a high of 0.9 in Q2 2022 and a low of 0.03 during Q1 2021
  • Its 5-year average for Equity Ratio is 0.8, with a median of 0.84 in 2025.
  • Its Equity Ratio has fluctuated over the past 5 years, first soared by 472036.56% in 2021, then plummeted by 967.05% in 2023.
  • Quarter analysis of 5 years shows Strata Critical Medical's Equity Ratio stood at 0.87 in 2021, then decreased by 2.65% to 0.84 in 2022, then dropped by 5.93% to 0.79 in 2023, then grew by 8.84% to 0.86 in 2024, then decreased by 2.32% to 0.84 in 2025.
  • Its Equity Ratio was 0.84 in Q3 2025, compared to 0.87 in Q2 2025 and 0.88 in Q1 2025.